Literature DB >> 20728524

Over-expression of major colonization factors of enterotoxigenic Escherichia coli, alone or together, on non-toxigenic E. coli bacteria.

Joshua Tobias1, Jan Holmgren, Maria Hellman, Erik Nygren, Michael Lebens, Ann-Mari Svennerholm.   

Abstract

Enterotoxigenic Escherichia coli (ETEC) is an important cause of diarrheal disease and deaths among children in developing countries and the major cause of traveller's diarrhea. Since surface protein colonization factors (CFs) of ETEC are important for pathogenicity and immune protection is mainly mediated by locally produced IgA antibodies in the gut, much effort has focused on the development of an oral CF-based vaccine. We have recently described the development of recombinant strains over-expressing CFA/I; the most prevalent CF among human clinical ETEC isolates. Here, non-toxigenic recombinant E. coli strains over-expressing Coli surface antigen 2 (CS2), CS4, CS5, and CS6, either alone, or each in combination with CFA/I were constructed by cloning the genes required for expression and assembly of each CF into expression vectors harboring a strong promoter. Immunological assays showed that recombinant strains expressing single CFs produced those in significantly larger amounts than did corresponding naturally high producing reference strains. Recombinant strains co-expressing CFA/I together with another CF also expressed significantly larger amounts of both CFs compared with the corresponding references strains. Further, when tested in mice, oral immunization with formalin-killed recombinant bacteria co-expressing one such double-expression CF pair, CFA/I+CS2, induced specific serum IgG+IgM and fecal IgA antibody responses against both CFs exceeding the responses induced by immunizations with natural reference strains expressing CFA/I and CS2, respectively. We conclude that the described type of recombinant bacteria over-expressing major CFs of ETEC, alone or in combination, may be useful as candidate strains for use in an oral whole-cell CF-ETEC vaccine.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20728524     DOI: 10.1016/j.vaccine.2010.08.047

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

1.  Multiepitope fusion antigen induces broadly protective antibodies that prevent adherence of Escherichia coli strains expressing colonization factor antigen I (CFA/I), CFA/II, and CFA/IV.

Authors:  Xiaosai Ruan; David E Knudsen; Katie M Wollenberg; David A Sack; Weiping Zhang
Journal:  Clin Vaccine Immunol       Date:  2013-12-18

Review 2.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

3.  Role of overexpressed CFA/I fimbriae in bacterial swimming.

Authors:  Ling Cao; Zhiyong Suo; Timothy Lim; Sangmu Jun; Muhammedin Deliorman; Carol Riccardi; Laura Kellerman; Recep Avci; Xinghong Yang
Journal:  Phys Biol       Date:  2012-05-04       Impact factor: 2.583

Review 4.  From cholera to enterotoxigenic Escherichia coli (ETEC) vaccine development.

Authors:  Ann-Mari Svennerholm
Journal:  Indian J Med Res       Date:  2011-02       Impact factor: 2.375

5.  Development of stable Vibrio cholerae O1 Hikojima type vaccine strains co-expressing the Inaba and Ogawa lipopolysaccharide antigens.

Authors:  Stefan L Karlsson; Elisabeth Ax; Erik Nygren; Susanne Källgård; Margareta Blomquist; Annelie Ekman; John Benktander; Jan Holmgren; Michael Lebens
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

6.  Stability of the Encoding Plasmids and Surface Expression of CS6 Differs in Enterotoxigenic Escherichia coli (ETEC) Encoding Different Heat-Stable (ST) Enterotoxins (STh and STp).

Authors:  Joshua Tobias; Astrid Von Mentzer; Patricia Loayza Frykberg; Martin Aslett; Andrew J Page; Åsa Sjöling; Ann-Mari Svennerholm
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

7.  The adjuvant double mutant Escherichia coli heat labile toxin enhances IL-17A production in human T cells specific for bacterial vaccine antigens.

Authors:  Susannah Leach; John D Clements; Joanna Kaim; Anna Lundgren
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

Review 8.  Pre-existing immunity against vaccine vectors--friend or foe?

Authors:  Manvendra Saxena; Thi Thu Hao Van; Fiona J Baird; Peter J Coloe; Peter M Smooker
Journal:  Microbiology       Date:  2012-11-22       Impact factor: 2.777

9.  A combined vaccine approach against Vibrio cholerae and ETEC based on outer membrane vesicles.

Authors:  Deborah R Leitner; Sabine Lichtenegger; Philipp Temel; Franz G Zingl; Desiree Ratzberger; Sandro Roier; Kristina Schild-Prüfert; Sandra Feichter; Joachim Reidl; Stefan Schild
Journal:  Front Microbiol       Date:  2015-08-11       Impact factor: 5.640

Review 10.  Intestinal Pathogenic Escherichia coli: Insights for Vaccine Development.

Authors:  Maricarmen Rojas-Lopez; Ricardo Monterio; Mariagrazia Pizza; Mickaël Desvaux; Roberto Rosini
Journal:  Front Microbiol       Date:  2018-03-20       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.